Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Calcific Aortic Valve Disease
NCT05875675Phase 2Not yet recruiting
- Start
- Jul 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pioglitazone in calcific aortic valve disease (CAVD), aortic valve stenosis. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
pioglitazone
03
Conditions
calcific aortic valve disease (CAVD)aortic valve stenosis
Beyond the preview
Go deeper on NCT05875675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05875675.